Tamoxifen is the most prescribed drug for the treatmentof breastcancer in premenopausal women and prevention of tumor recurrence.The anticancer effect is attributed to its ability to modulate estrogenreceptor activity, with the drug’s metabolites being more effectivethan the parent compound. Here, ESR1 is linked to neoplasm.